Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2007

01-11-2007 | Case Report

Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?

Authors: Hirokazu Okumura, Shigeki Ohtake, Yasuo Ontachi, Jun Ozaki, Shigeru Shimadoi, Yuko Waseda, Yukio Kondo, Hirohito Yamazaki, Akiyoshi Takami, Masahide Yasui, Hiroshi Date, Shinji Nakao

Published in: International Journal of Hematology | Issue 4/2007

Login to get access
Metadata
Title
Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?
Authors
Hirokazu Okumura
Shigeki Ohtake
Yasuo Ontachi
Jun Ozaki
Shigeru Shimadoi
Yuko Waseda
Yukio Kondo
Hirohito Yamazaki
Akiyoshi Takami
Masahide Yasui
Hiroshi Date
Shinji Nakao
Publication date
01-11-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.07045

Other articles of this Issue 4/2007

International Journal of Hematology 4/2007 Go to the issue

OriginalPaper

Activation of FKHRL1 Plays an Important Role in Protecting Erythroid Cells from Erythropoietin Deprivation-Induced Apoptosis in a Human Erythropoietin-Dependent Leukemia Cell Line, UT-7/EPO

Letter To The Editor

Acute-Onset Pancytopenia in a Postpartum Lactating Woman

Letter to the editor

NewHJV Mutation in a Patient with Hyperferritinemia and H63D Homozygosity for theHFE Gene

OriginalPaper

Advanced Stage Is the Most Important Prognostic Factor for Survival in Patients with Systemic Acquired Immunodeficiency Syndrome-Related Non-Hodgkin’s Lymphoma Treated with CHOP and Highly Active Antiretroviral Therapy

Progress in Hematology

Evolving New Treatment for Myelodysplastic Syndromes

OriginalPaper

High Frequency ofBCL2 Translocation in Thai Patients with Follicular Lymphomas
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits